文献速递口腔修复与种植口腔颌面外科

镁基可吸收生物材料:从生物学效应到临床应用

Magnesium-Based Resorbable Biomaterials: Biological Effects to Clinical Use.
PubMed 文献 · J Dent Res · 2025-10-16

本文综述镁基生物材料的生物学效应与临床潜力,重点聚焦口腔与颅颌面应用。镁基材料具备生物相容性、可降解性和适宜力学性能,可替代聚合物与永久金属用于植入物、网片和固定板,解决应力遮挡、炎症及二次取出手术等问题。其降解过程可逐步被自体组织替代并提供初期支撑,因此多数器械针对骨固定开发。临床上镁基可吸收膜与骨移植材料在引导骨/组织再生中显示潜力;美国有1个FDA批准的骨科镁基器械,欧洲和亚洲监管批准更多。主要局限包括降解的部位依赖性差异及镁作为生物制剂带来的监管复杂性。

要点

  • 镁基材料可降解并逐步被自体组织替代,避免二次取出手术。
  • 镁具有促骨生成、抗破骨和抗炎特性,可增强骨再生。
  • 临床审批存在地区差异,美国仅1个FDA批准的骨科镁基器械。

核心结论

  • 镁基生物材料生物相容、可降解且力学性能适宜,是聚合物和永久金属的有前景替代品。

研究设计与样本

  • 综述,总结镁基生物材料的生物学效应与临床潜力,重点覆盖口腔与颅颌面应用。

主要发现

  • 镁基材料可解决应力遮挡、炎症及取出手术需求,降解时提供初期支撑并逐步被自体组织替代。
  • 临床前研究显示镁具有促骨生成、抗破骨和抗炎特性,通过激活间充质干细胞信号通路和调节免疫反应增强骨再生。
  • 镁基可吸收膜和骨移植材料在引导骨/组织再生中显示临床潜力。

关键数值与推荐

  • 美国有1个FDA批准的骨科镁基器械,欧洲和亚洲监管批准更多。
  • 多数镁基器械针对骨固定应用开发。

临床怎么用

  • 镁基可吸收膜和骨移植材料可用于口腔引导骨/组织再生。
  • 利用镁生物特性的创新递送系统可能推进再生治疗。

局限性

  • 镁降解存在部位依赖性差异,影响临床可预测性。
  • 镁作为生物制剂增加监管流程复杂性,延迟广泛临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Magnesium (Mg) has emerged as a promising biomaterial, drawing significant attention for its potential in biomedical applications. As Mg-based products are in several clinical trials and in clinical use, it is timely to summarize the current knowledge of the biological effects and clinical potential with a special emphasis on oral and craniomaxillofacial applications. Mg-based biomaterials offer biocompatibility, biodegradability, and mechanical properties suitable for various clinical applications. These characteristics make them promising alternatives to polymers and permanent metals used in implantable devices, meshes, and fixation plates, effectively addressing challenges such as stress shielding, inflammation, and the need for removal surgeries. Their degradation enables gradual native tissue replacement while providing initial support, which is why most of the devices were developed for bone fixation applications. Clinically, Mg-based biomaterials such as resorbable membranes and bone grafts show potential in guided bone/tissue regeneration. In the United States, there is one FDA-approved Mg-based device for orthopedic applications compared with more regulatory approvals in Europe and Asia (at the time of writing). The main limitations that have delayed their widespread clinical use are the variable site-dependent degradation of Mg and Mg's effect as a biological agent, which adds another layer to the regulatory process. Studies show Mg's pro-osteogenic, anti-osteoclastic, and anti-inflammatory properties. Mg enhances bone regeneration by activating signaling pathways in mesenchymal stem cells and modulating the immune response. As research progresses, innovative Mg delivery systems leveraging its biological properties may utilize the potential of Mg-based biomaterials for advancing regenerative therapies. This review explores the following: (1) the current status of Mg-based biomaterials in clinical applications, (2) the corrosion properties of Mg metal devices and the biological interactions of degradation by-products, (3) the biological and immunomodulatory role of Mg in bone regeneration, and (4) the use of Mg-based biomaterials in oral and maxillofacial bone regeneration.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Lacin N, Sfeir C. Magnesium-Based Resorbable Biomaterials: Biological Effects to Clinical Use. J Dent Res. 2025. PMID: 41103022. doi:10.1177/00220345251368274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。